Pharma Journalist -

Abilita Bio, Inc. announced that it has entered into a multi-target research collaboration agreement with Amgen, a world leader in biotechnology. Under the terms of the agreement,…
Read More...

AbbVie, Teneobio, Inc. and its affiliate TeneoOne, Inc. announced that they have entered a global strategic transaction to develop and commercialize TNB-383B, a BCMA-targeting…
Read More...

Neurogene, Inc., a company founded with a mission to bring life-changing medicines to patients and families affected by rare neurological diseases, announced a $68.5 million Series A…
Read More...

Jubilant Biosys announced a new integrated drug discovery collaboration with Sanofi in the CNS therapeutic area. The first collaboration with Sanofi started in 2016, to discover and…
Read More...

Amyris, Inc. and IDRI (Infectious Disease Research Institute) announced IDRI’s receipt of a $4.4 million, five-year grant from the National Institute of Allergy and Infectious Diseases…
Read More...

SGS announced that it will commence its first Malaria Volunteer Infection Study (VIS) in Belgium in February 2019 on behalf of Medicines for Malaria Venture (MMV), a product development…
Read More...

Regeneron Pharmaceuticals and Sanofi announced that Praluent (alirocumab) will be made available at a new reduced U.S. list price of $5,850annually, a 60% reduction from the original…
Read More...

The Epilepsy Society and UCB, a global biopharmaceutical company headquartered in Belgium, with a significant UK R&D hub in Slough, UK, have announced an exciting new collaboration…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drug Advisory Committee and Drug Safety and…
Read More...

RegeneRx Biopharmaceuticals announced that ReGenTree, LLC, a joint venture between GtreeBNT and RegeneRx, has executed an agreement with Ora, Inc., located in Andover, Massachusetts,…
Read More...